1 Stock That Could Be the Next Big Thing After Palantir
When it comes to government relying on AI companies, Palantir seems to attract most investor attention and with good reason too.
Palantir is famous for big data analytics and analyzing massive amounts of information to make informed insights that can help government primarily, and increasingly commercial enterprises in sectors ranging from healthcare to finance.
The firm’s Gotham and Foundry platforms are widely relied upon and have produced large software contracts. » Read more about: 1 Stock That Could Be the Next Big Thing After Palantir »
Read More
1 Healthcare Stock That Is Seriously Undervalued
After a devastating few years, it is hard for any investor to deny that the economic climate is anything but bearish. With repeated global thrashings from the COVID-19 pandemic followed closely by sanctions against the Russian Federation, international investors have been left reeling.
But even in the darkest of times, there are a few rays of sunshine.
» Read more about: 1 Healthcare Stock That Is Seriously Undervalued »
Read More
Go to Cash or Keep Investing; Which Is Best?
Knowing the best course of action for your money can be challenging in uncertain times. Do you keep investing in stocks and hope the market rebounds? Or do you go to cash and wait for things to stabilize?
Both options have pros and cons, and deciding which is the right move for you can be challenging.
» Read more about: Go to Cash or Keep Investing; Which Is Best? »
Read More
92,214 Burger Joints But Only 1 Is a Meaty Buy
No matter the market conditions, some stocks stand the test of time as if economic booms and busts don’t matter. When you stumble across those stocks it’s worth seriously considering adding them to your portfolio.
Here’s why.
When markets fall, retail traders on average suffer more. One research report showed recently that with markets down 21% this year,
» Read more about: 92,214 Burger Joints But Only 1 Is a Meaty Buy »
Read More
Billionaire Builds Big Stake In Under-the-Radar ETF
George Soros had an old rule: invest first, investigate later. When a great opportunity seemed ripe for the picking, he would buy it, and figure out later if he was right.
It’s actually the opposite of what most funds do, which is to spend many months researching and dotting all their “i”s and crossing all their “t”s before patiently waiting for the price to get to the level they think is right.
» Read more about: Billionaire Builds Big Stake In Under-the-Radar ETF »
Read MoreThe Burst
Has This Massive Dividend Stock Fallen Off Radars?
Altria has fallen off many investors’ watchlists and with good reason. If any stock falls squarely into the category of sin stock, it’s the maker of Marlboro cigarettes. The tobacco manufacturer has been plagued with competition, regulatory obstacles, and a general trend towards increased wellness.
Imagine selling a product that comes with a government warning encouraging users not to buy it,
» Read more about: Has This Massive Dividend Stock Fallen Off Radars? »
Read MoreThe Spotlight
Is This the Safest Stock to Buy Today?
According to one study, when markets fell by 21%, retail portfolios were down by 32%. It’s been a devastating year for ordinary investors, which means “safe stocks” are back in vogue.
This desire for safer stocks is especially apparent among those who have seen firsthand that the “next big thing” can decline in price as quickly as it rises –
» Read more about: Is This the Safest Stock to Buy Today? »
Read MoreThe Daily
Why Novo Nordisk Stock Outpaced the Market Today and Hims & Hers Lagged It
Novo Nordisk‘s (NYSE: NVO) latest move in the retail sphere was met with approval from market participants Wednesday. They bid the stock up by nearly 4% following the company’s news, a performance that easily beat the recovering S&P 500‘s (SNPINDEX: ^GSPC) 1.1% gain.
» Read more about: Why Novo Nordisk Stock Outpaced the Market Today and Hims & Hers Lagged It »